| abstract |
The present invention includes mood disorders, anxiety disorders, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, eating disorders, hypertension, digestive disorders, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, Provided is a therapeutic or prophylactic agent for diseases such as head trauma, inflammation, immune-related diseases, and alopecia. Specifically, a condensed azole derivative represented by the general formula (I) having an arginine-vasopressin 1b receptor antagonistic action, or a pharmaceutically acceptable salt thereof is provided. [Chemical 1] |